Category: Cancer Treatment
Cancer Treatment market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Non-Hodgkin Lymphoma
The 2025-2030 World Outlook for Non-Hodgkin Lymphoma This study covers the world outlook for non-Hodgkin lymphoma across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More
-
The 2025-2030 World Outlook for Non-Hodgkin Lymphoma Treatments
The 2025-2030 World Outlook for Non-Hodgkin Lymphoma Treatments This study covers the world outlook for non-Hodgkin lymphoma treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Sarcoma Drugs
The 2025-2030 World Outlook for Sarcoma Drugs This study covers the world outlook for sarcoma drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), t ... Read More
-
The 2025-2030 World Outlook for Diagnostic Tests for Cervical Dysplasia
The 2025-2030 World Outlook for Diagnostic Tests for Cervical Dysplasia This study covers the world outlook for diagnostic tests for cervical dysplasia across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ... Read More
-
The 2025-2030 World Outlook for Next Generation Cancer Diagnostics
The 2025-2030 World Outlook for Next Generation Cancer Diagnostics This study covers the world outlook for next generation cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in ... Read More
-
The 2025-2030 World Outlook for 3D Cell Cultures for Cancer and Stem Cell Research
The 2025-2030 World Outlook for 3D Cell Cultures for Cancer and Stem Cell Research This study covers the world outlook for 3D cell cultures for cancer and stem cell research across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earni ... Read More
-
The 2025-2030 World Outlook for Blood Cancer Therapeutics
The 2025-2030 World Outlook for Blood Cancer Therapeutics This study covers the world outlook for blood cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2025-2030 World Outlook for Immunotherapy Drugs
The 2025-2030 World Outlook for Immunotherapy Drugs This study covers the world outlook for immunotherapy drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Medical Marijuana
The 2025-2030 World Outlook for Medical Marijuana This study covers the world outlook for medical marijuana across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2025-2030 World Outlook for NSCLC Therapeutics
The 2025-2030 World Outlook for NSCLC Therapeutics This study covers the world outlook for NSCLC therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More
-
The 2025-2030 World Outlook for Colorectal Cancer Monoclonal Antibodies (mAb)
The 2025-2030 World Outlook for Colorectal Cancer Monoclonal Antibodies (mAb) This study covers the world outlook for colorectal cancer monoclonal antibodies (mAb) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E ... Read More
-
The 2025-2030 World Outlook for Colorectal Cancers
The 2025-2030 World Outlook for Colorectal Cancers This study covers the world outlook for colorectal cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More
-
The 2025-2030 World Outlook for Targeted Therapy Liver Cancer Drugs
The 2025-2030 World Outlook for Targeted Therapy Liver Cancer Drugs This study covers the world outlook for targeted therapy liver cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2025-2030 World Outlook for Non-Melanoma Skin Cancers
The 2025-2030 World Outlook for Non-Melanoma Skin Cancers This study covers the world outlook for non-melanoma skin cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2025-2030 World Outlook for Noninvasive Cancer Diagnostics
The 2025-2030 World Outlook for Noninvasive Cancer Diagnostics This study covers the world outlook for noninvasive cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More
-
The 2025-2030 World Outlook for Lymphoma Treatments
The 2025-2030 World Outlook for Lymphoma Treatments This study covers the world outlook for lymphoma treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Malignant Melanoma Treatments
The 2025-2030 World Outlook for Malignant Melanoma Treatments This study covers the world outlook for malignant melanoma treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
-
The 2025-2030 World Outlook for Bile Duct Cancer (Cholangiocarcinoma) Treatments
The 2025-2030 World Outlook for Bile Duct Cancer (Cholangiocarcinoma) Treatments This study covers the world outlook for bile duct cancer (cholangiocarcinoma) treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ... Read More
-
The 2025-2030 World Outlook for Alkylating Gynaecological Cancer Drugs
The 2025-2030 World Outlook for Alkylating Gynaecological Cancer Drugs This study covers the world outlook for alkylating gynaecological cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co ... Read More
-
The 2025-2030 World Outlook for Cancer Cachexia
The 2025-2030 World Outlook for Cancer Cachexia This study covers the world outlook for cancer cachexia across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars ... Read More
-
The 2025-2030 World Outlook for In Vitro Colorectal Cancer Testing
The 2025-2030 World Outlook for In Vitro Colorectal Cancer Testing This study covers the world outlook for in vitro colorectal cancer testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in ... Read More
-
The 2025-2030 World Outlook for Colorectal Cancer Treatments
The 2025-2030 World Outlook for Colorectal Cancer Treatments This study covers the world outlook for colorectal cancer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for Amyloidosis Treatments
The 2025-2030 World Outlook for Amyloidosis Treatments This study covers the world outlook for amyloidosis treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Breast Cancer Diagnostic and Drugs
The 2025-2030 World Outlook for Breast Cancer Diagnostic and Drugs This study covers the world outlook for breast cancer diagnostic and drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in ... Read More
-
The 2025-2030 World Outlook for Breast Cancer Diagnostics and Drug Technologies
The 2025-2030 World Outlook for Breast Cancer Diagnostics and Drug Technologies This study covers the world outlook for breast cancer diagnostics and drug technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P ... Read More
Research Assistance
